Evolus (EOLS) Revenue & Revenue Breakdown
Evolus Revenue Highlights
Latest Revenue (Y)
$264.31M
Latest Revenue (Q)
$68.70M
Main Segment (Y)
Product
Main Geography (Y)
UNITED STATES
Evolus Revenue by Period
Evolus Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $264.31M | 30.79% |
| 2023-12-31 | $202.09M | 35.98% |
| 2022-12-31 | $148.62M | 49.10% |
| 2021-12-31 | $99.67M | 76.29% |
| 2020-12-31 | $56.54M | 61.89% |
| 2019-12-31 | $34.92M | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | - |
Evolus generated $264.31M in revenue during NA 2024, up 30.79% compared to the previous quarter, and up 756.78% compared to the same period a year ago.
Evolus Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $68.70M | 0.92% |
| 2025-03-31 | $68.07M | -13.77% |
| 2024-12-31 | $78.95M | 29.24% |
| 2024-09-30 | $61.09M | -8.70% |
| 2024-06-30 | $66.91M | 12.77% |
| 2024-03-31 | $59.33M | -2.73% |
| 2023-12-31 | $61.00M | 23.67% |
| 2023-09-30 | $49.32M | -0.05% |
| 2023-06-30 | $49.35M | 18.28% |
| 2023-03-31 | $41.72M | -4.41% |
| 2022-12-31 | $43.65M | 28.75% |
| 2022-09-30 | $33.90M | -8.78% |
| 2022-06-30 | $37.16M | 9.60% |
| 2022-03-31 | $33.91M | -2.16% |
| 2021-12-31 | $34.66M | 29.91% |
| 2021-09-30 | $26.68M | 2.22% |
| 2021-06-30 | $26.10M | 113.20% |
| 2021-03-31 | $12.24M | -40.51% |
| 2020-12-31 | $20.58M | 16.51% |
| 2020-09-30 | $17.66M | 126.25% |
| 2020-06-30 | $7.81M | -25.63% |
| 2020-03-31 | $10.50M | -46.03% |
| 2019-12-31 | $19.45M | 47.69% |
| 2019-09-30 | $13.17M | 469.75% |
| 2019-06-30 | $2.31M | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | - |
Evolus generated $68.70M in revenue during Q2 2025, up 0.92% compared to the previous quarter, and up 115.79% compared to the same period a year ago.
Evolus Revenue Breakdown
Evolus Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Service | $1.97M | $2.36M | $2.02M | - | - |
| Product | $264.31M | $199.72M | $146.59M | $98.97M | $55.80M |
Evolus's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (99.26%), and Service (0.74%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $68.70M | $68.07M | $78.96M | $60.16M | $66.22M | $58.96M | $60.67M | $49.32M | $48.68M | $41.05M | $42.99M | $33.22M | $37.16M | $33.23M | $34.66M | $26.68M | $25.40M | $20.58M | $16.92M |
| Service | $688.00K | $448.00K | - | $921.00K | $687.00K | $369.00K | $328.00K | $696.00K | $666.00K | $674.00K | $658.00K | $684.00K | - | - | - | - | - | - | - |
Evolus's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Product (99.01%), and Service (0.99%).
Evolus Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 21 | Dec 20 |
|---|---|---|---|
| UNITED STATES | $253.16M | - | - |
| Non-US | $13.12M | - | - |
| CANADA | - | $702.00K | $738.00K |
Evolus's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (95.07%), and Non-US (4.93%).
Quarterly Revenue by Country
| Country | Mar 22 | Jun 21 | Sep 20 |
|---|---|---|---|
| CANADA | $682.00K | $702.00K | $738.00K |
Evolus's latest quarterly revenue breakdown by geography, as of Mar 22: CANADA (100.00%).
Evolus Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CYH | Community Health Systems | $12.63B | $3.09B |
| EBS | Emergent BioSolutions | $1.04B | $140.90M |
| EHAB | Enhabit | $1.03B | $266.10M |
| EOLS | Evolus | $264.31M | $68.70M |
| TMCI | Treace Medical Concepts | $209.36M | $52.57M |
| AMRN | Amarin | $204.59M | $46.62M |
| KMDA | Kamada | $144.76M | $37.40M |
| KRRO | Korro Bio | $2.27M | $2.55M |
| CLLS | Cellectis | $755.00K | $4.53M |
| RAPT | RAPT Therapeutics | - | - |